Elevated Plasma Osteopontin Level is Associated with Pelvic Inflammatory Disease

Reproductive Sciences

Volumn 17, Issue 11, 2010, Pages 1052-1058

  Wang, Po Hui ^a,b   Liu, Yu Fan ^b   Tsai, Hsiu Ting ^a,b   Tee, Yi Torng ^a,b   Lin, Long Yau ^a,b   Hsieh, Yi Hsien ^b   Yang, Shun Fa ^a,b  

^a CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

Author keywords

osteopontin; pelvic inflammatory disease; single nucleotide polymorphism

Indexed keywords

C REACTIVE PROTEIN; OSTEOPONTIN;

ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; DNA EXTRACTION; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; HUMAN CELL; INFECTION RISK; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; NEUTROPHIL COUNT; OSTEOPONTIN BLOOD LEVEL; PELVIC INFLAMMATORY DISEASE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM;

BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FEMALE; HUMANS; OSTEOPONTIN; PELVIC INFLAMMATORY DISEASE; SENSITIVITY AND SPECIFICITY;

EID: 77958003048     PISSN: 19337191     EISSN: 19337205     Source Type: Journal    
DOI: 10.1177/1933719110379270     Document Type: Article

References (24)

1. Wolner-Hanssen P. Silent pelvic inflammatory disease: is it overstated. Obstet Gynecol. 1995 ; 86 (3). 321-325.
2. Denhardt DT, Noda M., O'Regan AW, Pavlin D., Berman JS Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival. J Clin Invest. 2001 ; 107 (9). 1055-1061.
3. Reinholt FP, Hultenby K., Oldberg A., Heinegard D. Osteopontin- a possible anchor of osteoclasts to bone. Proc Natl Acad Sci USA. 1990 ; 87 (12). 4473-4475.
4. Young MF, Kerr JM, Termine JD, et al. cDNA cloning, mRNA distribution and heterogeneity, chromosomal location, and RFLP analysis of human osteopontin (OPN). Genomics. 1990 ; 7 (4). 491-502.
5. Craig AM, Denhardt DT The murine gene encoding secreted phosphoprotein 1 (osteopontin): promoter structure, activity, and induction in vivo by estrogen and progesterone. Gene. 1991 ; 100: 163-171.
6. Singh RP, Patarca R., Schwartz J., Singh P., Cantor H. Definition of a specific interaction between the early T lymphocyte activation 1 (Eta-1) protein and murine macrophages in vitro and its effect upon macrophages in vivo. J Exp Med. 1990 ; 171 (6). 1931-1942.
7. Yu XQ, Nikolic-Paterson DJ, Mu W., Giachelli CM, Atkins RC, Johnson RJ, et al. A functional role for osteopontin in experimental crescentic glomerulonephritis in the rat. Proc Assoc Am Physicians. 1998 ; 110 (1). 50-64. (Pubitemid 28051638)
8. Barrett JC, Fry B., Maller J., Daly MJ Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005 ; 21 (2). 263-265.
9. Forton AC, Petri MA, Goldman D., Sullivan KE An osteopontin (SPP1) polymorphism is associated with systemic lupus erythematosus. Hum Mutat. 2002 ; 19 (4). 459-462.
10. Niino M., Kikuchi S., Fukazawa T., Yabe I., Tashiro K. Genetic polymorphisms of osteopontin in association with multiple sclerosis in Japanese patients. J Neuroimmunol. 2003 ; 136 (1-2). 125-129. (Pubitemid 36298851)
11. Centers for Disease Control and Prevention. Workowski KA, Berman SM Sexually transmitted diseases treatment guidelines, 2006. MMWR Recomm Rep. 2006 ; 55 (RR-11). 1-94.
12. O'Regan A., Berman JS Osteopontin: a key cytokine in cell-mediated and granulomatous inflammation. Int J Exp Pathol. 2000 ; 81 (6). 373-390.
13. Fisher LW, Torchia DA, Fohr B., Young MF, Fedarko NS Flexible structures of SIBLING proteins, bone sialoprotein, and osteopontin. Biochem Biophys Res Commun. 2001 ; 280 (2). 460-465.
14. Oldberg A., Franzen A., Heinegard D. Cloning and sequence analysis of rat bone sialoprotein (osteopontin) cDNA reveals an Arg-Gly-Asp cell-binding sequence. Proc Natl Acad Sci USA. 1986 ; 83 (23). 8819-8823.
15. Nishimichi N., Higashikawa F., Kinoh HH, Tateishi Y., Matsuda H., Yokosaki Y. Polymeric osteopontin employs integrin alpha 9beta 1 as a receptor and attracts neutrophils by presenting a de novo binding site. J Biol Chem. 2009 ; 284 (22). 14769-14776.
16. Light WR, MacGregor MI, Luchsinger PC, Ball WC Jr. Pleural effusions: the diagnostic separation of transudations and exudates. Ann Intern Med. 1972 ; 77 (4). 507-514.
17. Grove CS, Lee YCG. Vascular endothelial growth factor: the key mediator in pleural effusion formation. Curr Opin Pulm Med. 2002 ; 8 (4). 294-301.
18. Elsammak MMY, Morsi TS, Khamis HI, Ragab MS, Zaki MA, Abdel-Hadi M., et al. Osteopontin and C-reactive protein in Egyptian patients affected with tuberculous and malignant pleural effusion. Ann Clin Biochem. 2007 ; 44 (pt 3). 264-272.
19. Xu G., Sun W., He D., Wang L., Zheng W., Nie H., et al. Overexpression of osteopontin in rheumatoid synovial mononuclear cells is associated with joint inflammation, not with genetic polymorphism. J Rheumatol. 2005 ; 32 (3). 410-416.
20. Emani S., Zhang J., Guo L., Guo H., Kuo PC RNA stability regulates differential expression of the metastasis protein, osteopontin, in hepatocellular cancer. Surgery. 2008 ; 143 (6). 803-812.
21. Zhang J., Guo H., Mi Z., et al. EF1A1-actin interactions alter mRNA stability to determine differential osteopontin expression in HepG2 and Hep3B cells. Exp Cell Res. 2009 ; 315 (2). 304-312.
22. Chen CY, Shyu AB AU-rich elements: characterization and importance in mRNA degradation. Trends Biochem Sci. 1995 ; 20 (11). 465-470.
23. Hu J., Lutz CS, Wilusz J., Tian B. Bioinformatic identification of candidate cis-regulatory elements involved in human mRNA polyadenylation. RNA. 2005 ; 11 (10). 1485-1493.
24. Peipert JF, Boardman L., Hogan JW, Sung J., Mayer KH Laboratory evaluation of acute upper genital tract infection. Obstet Gynecol. 1996 ; 87 (5 pt 1). 730-736.